Forum: Initiatives in place to ensure responsible use of precision medicine
We thank Ms. Grace Chua Siew Hwee for her letter, “Concerns over how SG100K DNA mapping will affect S’poreans” (May 31).
Precision medicine has been identified as an important strategy to support a healthier population and improve healthcare outcomes.
When applied appropriately, precision medicine could identify groups at higher risk for chronic disease to begin preventive care early.
This could involve low-cost interventions or lifestyle adjustments, which are more cost-effective than the downstream treatments needed for chronic diseases.
To ensure responsible use of precision medicine, Precision Health Research Singapore (Precise) and the Ministry of Health (MOH) have also launched a number of initiatives.
The MOH developed the Code of Practice on Standards for the Provision of Clinical Genetic/Genomic Testing Services and Clinical Laboratory Genetic/Genomic Testing Services in 2018 to guide physicians on safe practices and best practices for providing clinical laboratory services. clinical genetic testing services.
A moratorium on genetic testing and insurance was put in place by the Life Insurance Association last year to ensure that all genetic test results from biomedical research and predictive genetic testing are not used in insurance underwriting, except those based on solid scientific evidence (e.g. Huntington’s disease) and for high value insurance contracts.
The Singapore Bioethics Advisory Committee also develops national advisory reports to guide researchers, academics and healthcare professionals on the ethical and responsible use of genomic data.
We are constantly reviewing developments in this area and conducting our own research to validate the usefulness of different precision medicine approaches.
Tan Chorh Chuan (Professor)
Chief Health Scientist
Ministry of Health
Patrick Tan (Professor)
Singapore Precision Health Research
Comments are closed.